BridgeBio Pharma, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 10,242 | 0.0% | 133,906 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 6,955 | 0.0% | 133,898 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 5,781 | 0.0% | 133,891 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 4,199 | 0.0% | 121,474 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 3,174 | 0.0% | 115,655 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 2,756 | 0.0% | 108,267 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 2,782 | 0.0% | 109,817 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 3,265 | 0.0% | 105,596 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,974 | 0.0% | 98,443 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 2,725 | 0.0% | 103,333 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,989 | 0.0% | 115,626 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 1,633 | 0.0% | 98,487 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 766 | 0.0% | 100,537 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 979 | 0.0% | 98,503 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 920 | 0.0% | 101,353 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 990 | 0.0% | 97,539 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 1,912 | 0.0% | 114,645 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 5,302 | 0.0% | 113,122 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 9,041 | 0.0% | 148,304 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 8,742 | 0.0% | 141,910 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 7,837 | 0.0% | 110,215 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 4,135 | 0.0% | 110,202 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 3,581 | 0.0% | 109,805 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 3,302 | 0.0% | 113,860 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,210 | 0.0% | 34,510 | 12/31/2019 |